An emerging treatment option for glaucoma: Rho kinase inhibitors
about
The progress in optic nerve regeneration, where are we?One Year of Glaucoma Research in Review-2013 to 2014Glaucoma: the retina and beyondTargeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations.Human airway musculature on a chip: an in vitro model of allergic asthmatic bronchoconstriction and bronchodilation.Cross-talk between ciliary epithelium and trabecular meshwork cells in-vitro: a new insight into glaucomaDexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells, and MatrixDiscovery of novel inhibitors for the treatment of glaucoma.Genes, pathways, and animal models in primary open-angle glaucoma.Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.Cross-linked actin networks (CLANs) in glaucoma.Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury.TGFβ2-induced outflow alterations in a bioengineered trabecular meshwork are offset by a rho-associated kinase inhibitor.ROCK Inhibition Promotes Attachment, Proliferation, and Wound Closure in Human Embryonic Stem Cell-Derived Retinal Pigmented EpitheliumROCK regulates the intermittent mode of interstitial T cell migration in inflamed lungs.Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma.Biomechanical, ultrastructural, and electrophysiological characterization of the non-human primate experimental glaucoma model.Experimental research on the relationship between the stiffness and the expressions of fibronectin proteins and adaptor proteins of rat trabecular meshwork cells.Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.GCDB: a glaucomatous chemogenomics database for in silico drug discoveryTGF-β-induced IOP elevations are mediated by RhoA in the early but not the late fibrotic phase of open angle glaucoma
P2860
Q26765313-D8D1CC15-8AE9-419C-B703-AB13B3BD7DAAQ26801395-887CBD44-F6FC-44DC-9E1E-A765412279D8Q28077518-2324D360-A8D9-4731-9510-92BA79D1BAB7Q33665753-D0743A58-099F-4152-A0C3-64006CC7A721Q34205274-D7827311-B354-4538-A996-E15356E339CAQ35412562-42FECD76-1E67-4079-9D9A-B283B09DEBACQ35870345-2A2A3047-8AFA-487E-8E6B-66F79DE16D06Q36108207-0F47AE89-4752-4A02-A7D0-6E2584E30D26Q36750385-4E60F90C-3768-43A7-8881-C1D13FCDC21CQ38584194-F72BEB71-70F2-4079-B215-0491D69E74EAQ39151617-198C2B6E-C5BA-4DB2-A98C-7E9C5D62273BQ39575164-98B77AA2-19FC-4FFC-BCBE-4E2A794A392BQ42011324-4D905E6C-AEA0-4819-88BC-9918C27CA901Q42360527-BC528335-41C0-495E-A409-73AAB51B6524Q42380167-84C8F8A1-69C4-4FE0-AF76-F9A930DA3BEDQ43102763-A3D59516-7F9E-4F11-BB41-8B56208F73D0Q44977209-2C95993B-9C96-4FC3-9054-5F319EF402F8Q47114071-9C63D968-636D-421E-A4BD-6C4D99894A32Q50947105-C9AF19A7-8811-4B43-88DA-A4EA3473CC8CQ58132502-F3A1E6AF-0B94-40E3-98DB-734670E6E54AQ59138459-19BA278E-854C-470C-923E-ACF83A8C1F59
P2860
An emerging treatment option for glaucoma: Rho kinase inhibitors
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
An emerging treatment option for glaucoma: Rho kinase inhibitors
@ast
An emerging treatment option for glaucoma: Rho kinase inhibitors
@en
An emerging treatment option for glaucoma: Rho kinase inhibitors
@en-gb
An emerging treatment option for glaucoma: Rho kinase inhibitors
@nl
type
label
An emerging treatment option for glaucoma: Rho kinase inhibitors
@ast
An emerging treatment option for glaucoma: Rho kinase inhibitors
@en
An emerging treatment option for glaucoma: Rho kinase inhibitors
@en-gb
An emerging treatment option for glaucoma: Rho kinase inhibitors
@nl
prefLabel
An emerging treatment option for glaucoma: Rho kinase inhibitors
@ast
An emerging treatment option for glaucoma: Rho kinase inhibitors
@en
An emerging treatment option for glaucoma: Rho kinase inhibitors
@en-gb
An emerging treatment option for glaucoma: Rho kinase inhibitors
@nl
P2860
P3181
P356
P1476
An emerging treatment option for glaucoma: Rho kinase inhibitors
@en
P2093
Robert Chang
P2860
P3181
P356
10.2147/OPTH.S41000
P407
P577
2014-05-01T00:00:00Z